Detalhe da pesquisa
1.
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.
N Engl J Med
; 377(13): 1228-1239, 2017 09 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-28910237
2.
Baseline characteristics of patients enrolled in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL).
Am Heart J
; 187: 1-9, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28454792
3.
Effects of Once-Weekly Exenatide on Clinical Outcomes in Patients With Preexisting Cardiovascular Disease.
Circulation
; 138(22): 2576-2578, 2018 11 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30571356
4.
Changes in Serum Calcitonin Concentrations, Incidence of Medullary Thyroid Carcinoma, and Impact of Routine Calcitonin Concentration Monitoring in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL).
Diabetes Care
; 42(6): 1075-1080, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31010875
5.
ADAMTS4 (aggrecanase-1) cleaves human brain versican V2 at Glu405-Gln406 to generate glial hyaluronate binding protein.
Biochem J
; 377(Pt 3): 787-95, 2004 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-14561220
6.
Rate versus rhythm control and outcomes in patients with atrial fibrillation and chronic kidney disease: data from the GUSTO-III Trial.
Cardiol J
; 20(4): 439-46, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23913464
7.
A randomized, double-blind, active-controlled phase 2 trial to evaluate a novel selective and reversible intravenous and oral P2Y12 inhibitor elinogrel versus clopidogrel in patients undergoing nonurgent percutaneous coronary intervention: the INNOVATE-PCI trial.
Circ Cardiovasc Interv
; 5(3): 336-46, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22647518
8.
Usefulness of the Duke Sudden Cardiac Death risk score for predicting sudden cardiac death in patients with angiographic (>75% narrowing) coronary artery disease.
Am J Cardiol
; 104(12): 1624-30, 2009 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19962465
9.
ADAMTS4 (aggrecanase-1) activation on the cell surface involves C-terminal cleavage by glycosylphosphatidyl inositol-anchored membrane type 4-matrix metalloproteinase and binding of the activated proteinase to chondroitin sulfate and heparan sulfate on syndecan-1.
J Biol Chem
; 279(11): 10042-51, 2004 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-14701864
10.
Activation of the proteolytic activity of ADAMTS4 (aggrecanase-1) by C-terminal truncation.
J Biol Chem
; 277(13): 11034-41, 2002 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-11796708
11.
ADAMTS4 cleaves at the aggrecanase site (Glu373-Ala374) and secondarily at the matrix metalloproteinase site (Asn341-Phe342) in the aggrecan interglobular domain.
J Biol Chem
; 277(18): 16059-66, 2002 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-11854269